1 / 10

10% Discount on Personalized Medicine Market(Valid till 30th Sept 2016)

Bharat Book Bureau provides the report, on "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment”. https://www.bharatbook.com/healthcare-market-research-reports-433355/personalized-medicine-targeted-therapeutics-companion-diagnostic.html This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments.<br>

bharatbookseo
Download Presentation

10% Discount on Personalized Medicine Market(Valid till 30th Sept 2016)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 10% Discount (Valid till 30th Sept 2016) Personalized Medicine, Targeted Therapeutics & Companion Diagnostic Market

  2. Summary This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 360 tables & figures over 393 pages. The personalized medicine (global & USA) market is presented as follows:• By Company (e.g., Qiagen, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD) • By Segment (Targeted therapeutics, Companion Diagnostics, Liquid Biopsies) • By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics, liquid biopsy) • By Therapy (Cancer, Cardiovascular, Infectious Disease)

  3. A wealth of financial data & business strategy • Company financials, sales & revenue figures• Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies• Business Model Strategies for Providers. Provider Systems and Academic Medical Centre• Business Model Strategies for Payers & Governments• Private and Public Funding and Personalized Medicine Reimbursement • Revisions to Current Payment Systems and intellectual property• How to Gain Market Penetration in the EU

  4. SWOT, Economic & Regulatory Environment • Key strengths, weaknesses and threats influencing leading player position • Top fastest growing market segments and emerging opportunities• Top pharmaceutical companies within the IPM by market share and revenue• Comprehensive product portfolios, R&D activity and pipeline therapeutics • M&A activity and future strategies of top personalized medicine pharmacos• Personalized Medicine Regulation (USA, UK, Germany, France, Spain, Italy)• CE-marked Personalized Medicine/Diagnostic Tests

  5. What you will gain: • An in-depth understanding of the global personalized medicine market and it’s environment• Current market facts, figures and product lines of key players in the industry• Emerging trends in key markets such as the US, UK, Germany and France• Technical insights into new generation sequencing technologies and ultra-high throughput sequencing• FDA approved pharmacogenetic tests and recognized biomarkers

  6. Who should read this report? • Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine• Industry professionals and business strategists will discover key information to propel their policies• Investors will gain inside information to dominant players in the industry• Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment

  7. Executive Summary Cutting-edge new research by KellySciPub indicates that the core personalized medicine market will be worth over $149 billion by 2020 with a CAGR of 8.74%. This market is made up of companion diagnostics and targeted therapeutics and is dominated by oncology, cardiovascular and infectious disease treatment and diagnostics. The report ‘Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market: Strategic Analysis of Industry Trends, Technologies, Participants, and Environment’ has already been procured by 21 of the top 25 Pharma companies globally. This newly published edition gives a revolutionary insight into the vertical growing market of personalized healthcare globally.

  8. Table Of Content Executive Summary Introduction and Background Personalized Medicine Targeted Therapeutics and Associated Companion Diagnostics Personalized Medicine and Integration into the Healthcare System Private and Public Funding and Personalized Medicine Reimbursement European Personalized Medicine Market – Payments and Investment Personalized Medicine –Business Model Analysis Personalized Medicine Main Industry Players

  9. Contact Us Full Report : Personalized Medicine Market Report Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: poonam@bharatbook.com Website: www.bharatbook.com FaceBook : BharatBook3B Twitter : ResearchBook LinkedIn : Bharat Book Bureau

More Related